Xtant Medical Holdings, Inc. XTNT

Company Overview

Xtant Medical Holdings, Inc. is a U.S.-based medical technology company focused on regenerative medicine products and surgical solutions for the treatment of spinal, orthopedic, and certain neurosurgical conditions. The company operates primarily within the biologics and medical device sectors, developing and distributing implants, allografts, fixation systems, and orthobiologic products used by surgeons in complex musculoskeletal procedures. Its revenue base is largely driven by spinal implant systems, biologic graft products, and related surgical instrumentation sold to hospitals, ambulatory surgery centers, and surgeons.

The company traces its origins to the spinal implant business formerly known as Bacterin International Holdings, Inc., which later rebranded as Xtant Medical Holdings, Inc. as it expanded beyond tissue processing into a broader portfolio of spinal and orthopedic technologies. Xtant has positioned itself as a specialized provider serving spine surgeons seeking biologic and fixation solutions across cervical, thoracolumbar, and sacroiliac procedures. Its strategic positioning has emphasized a combination of biologics expertise, surgeon-focused product development, and a diversified portfolio intended to compete in niche and mid-sized segments of the spinal device market.